BACKGROUND: Based on studies in animals and humans, PAX3 and T (brachyury) are candidate genes for spina bifida. However, neither gene has been definitively identified as a risk factor for this condition. METHODS: Sanger sequencing was used to identify variants in all PAX3 and T exons and promoter regions in 114 spina bifida cases. For known variants, allele frequencies in cases were compared with those from public databases using unadjusted odds ratios. Novel variants were genotyped in parents and assessed for predicted functional impact. RESULTS: We identified common variants in PAX3 (n = 2) and T (n = 3) for which the allele frequencies in cases were significantly different from those reported in at least one public database. We also identified novel variants in both PAX3 (n = 11) and T (n = 1) in spina bifida cases. Several of the novel PAX3 variants are predicted to be highly conserved and/or impact gene function or expression. CONCLUSION: These studies provide some evidence that common variants of PAX3 and T are associated with spina bifida. Rare and novel variants in these genes were also identified in affected individuals. However, additional studies will be required to determine whether these variants influence the risk of spina bifida.
BACKGROUND: Based on studies in animals and humans, PAX3 and T (brachyury) are candidate genes for spina bifida. However, neither gene has been definitively identified as a risk factor for this condition. METHODS: Sanger sequencing was used to identify variants in all PAX3 and T exons and promoter regions in 114 spina bifida cases. For known variants, allele frequencies in cases were compared with those from public databases using unadjusted odds ratios. Novel variants were genotyped in parents and assessed for predicted functional impact. RESULTS: We identified common variants in PAX3 (n = 2) and T (n = 3) for which the allele frequencies in cases were significantly different from those reported in at least one public database. We also identified novel variants in both PAX3 (n = 11) and T (n = 1) in spina bifida cases. Several of the novel PAX3 variants are predicted to be highly conserved and/or impact gene function or expression. CONCLUSION: These studies provide some evidence that common variants of PAX3 and T are associated with spina bifida. Rare and novel variants in these genes were also identified in affected individuals. However, additional studies will be required to determine whether these variants influence the risk of spina bifida.
Authors: D Trembath; A L Sherbondy; D C Vandyke; G M Shaw; K Todoroff; E J Lammer; R H Finnell; S Marker; G Lerner; J C Murray Journal: Teratology Date: 1999-05
Authors: F A Hol; M P Geurds; S Chatkupt; Y Y Shugart; R Balling; C T Schrander-Stumpel; W G Johnson; B C Hamel; E C Mariman Journal: J Med Genet Date: 1996-08 Impact factor: 6.318
Authors: E C Melvin; T M George; G Worley; A Franklin; J Mackey; K Viles; N Shah; C R Drake; D S Enterline; D McLone; J Nye; W J Oakes; C McLaughlin; M L Walker; P Peterson; T Brei; C Buran; J Aben; B Ohm; I Bermans; M Qumsiyeh; J Vance; M A Pericak-Vance; M C Speer Journal: Pediatr Neurosurg Date: 2000-01 Impact factor: 1.162
Authors: K Morrison; C Papapetrou; J Attwood; F Hol; S A Lynch; A Sampath; B Hamel; J Burn; J Sowden; D Stott; E Mariman; Y H Edwards Journal: Hum Mol Genet Date: 1996-05 Impact factor: 6.150
Authors: S Chatkupt; F A Hol; Y Y Shugart; M P Geurds; E S Stenroos; M R Koenigsberger; B C Hamel; W G Johnson; E C Mariman Journal: J Med Genet Date: 1995-03 Impact factor: 6.318
Authors: Tonia C Carter; Faith Pangilinan; James F Troendle; Anne M Molloy; Julia VanderMeer; Adam Mitchell; Peadar N Kirke; Mary R Conley; Barry Shane; John M Scott; Lawrence C Brody; James L Mills Journal: Am J Med Genet A Date: 2010-12-10 Impact factor: 2.802
Authors: Tianyu Zhao; Qini Gan; Arjun Stokes; Rhonda N T Lassiter; Yongping Wang; Jason Chan; Jane X Han; David E Pleasure; Jonathan A Epstein; Chengji J Zhou Journal: Development Date: 2013-11-27 Impact factor: 6.868
Authors: Philip J Lupo; A J Agopian; Heidi Castillo; Jonathan Castillo; Gerald H Clayton; Nienke P Dosa; Betsy Hopson; David B Joseph; Brandon G Rocque; William O Walker; John S Wiener; Laura E Mitchell Journal: J Pediatr Rehabil Med Date: 2017-12-11
Authors: Antigoni Gogolou; Celine Souilhol; Ilaria Granata; Filip J Wymeersch; Ichcha Manipur; Matthew Wind; Thomas J R Frith; Maria Guarini; Alessandro Bertero; Christoph Bock; Florian Halbritter; Minoru Takasato; Mario R Guarracino; Anestis Tsakiridis Journal: Elife Date: 2022-09-26 Impact factor: 8.713
Authors: Youssef A Kousa; Huiping Zhu; Walid D Fakhouri; Yunping Lei; Akira Kinoshita; Raeuf R Roushangar; Nicole K Patel; A J Agopian; Wei Yang; Elizabeth J Leslie; Tamara D Busch; Tamer A Mansour; Xiao Li; Arianna L Smith; Edward B Li; Dhruv B Sharma; Trevor J Williams; Yang Chai; Brad A Amendt; Eric C Liao; Laura E Mitchell; Alexander G Bassuk; Simon Gregory; Allison Ashley-Koch; Gary M Shaw; Richard H Finnell; Brian C Schutte Journal: Hum Mol Genet Date: 2019-05-15 Impact factor: 6.150